In recent years, governmental pressure on reducing the cost of drugs, together with the growth in the number of generic manufacturers, have given a considerable boost to competition in the pharmaceutical sector. Such relevant market change has highlighted the necessity of controlling and improving performance in order to reduce costs while maintaining high qualitylevels, both enhancing working capital management and increasing overall equipment effectiveness (OEE) of production lines (activities that had previously been somewhat neglected in the pharmaceutical sector). In this paper, the paradigm of buffer design for availability (BDFA) - an approach developed to conciliate these apparently conflicting strategies to achieve performance improvement and cost reduction - is briefly recalled and discussed, being contextualized in the state-of-the-art of buffer design research. Its valuable practical applicability and effectiveness is then demonstrated by the means of a real case study application, and future developments are eventually presented.

Benedetti, M., Cesarotti, V., Giuiusa, A., Introna, V. (2014). Buffer size design in pharmaceutical packaging lines: An analytical methodology proposal and case study. INTERNATIONAL JOURNAL OF ENGINEERING BUSINESS MANAGEMENT, 6(1), 1-10 [10.5772/58938].

Buffer size design in pharmaceutical packaging lines: An analytical methodology proposal and case study

CESAROTTI, VITTORIO;INTRONA, VITO
2014-01-01

Abstract

In recent years, governmental pressure on reducing the cost of drugs, together with the growth in the number of generic manufacturers, have given a considerable boost to competition in the pharmaceutical sector. Such relevant market change has highlighted the necessity of controlling and improving performance in order to reduce costs while maintaining high qualitylevels, both enhancing working capital management and increasing overall equipment effectiveness (OEE) of production lines (activities that had previously been somewhat neglected in the pharmaceutical sector). In this paper, the paradigm of buffer design for availability (BDFA) - an approach developed to conciliate these apparently conflicting strategies to achieve performance improvement and cost reduction - is briefly recalled and discussed, being contextualized in the state-of-the-art of buffer design research. Its valuable practical applicability and effectiveness is then demonstrated by the means of a real case study application, and future developments are eventually presented.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore ING-IND/17 - Impianti Industriali Meccanici
English
Senza Impact Factor ISI
Buffer Design for Availability, Overall Equipment Effectiveness, Pharmaceutical Industry
http://www.intechopen.com/journals/international_journal_of_engineering_business_management/buffer-size-design-in-pharmaceutical-packaging-lines-an-analytical-methodology-proposal-and-case-stu
Benedetti, M., Cesarotti, V., Giuiusa, A., Introna, V. (2014). Buffer size design in pharmaceutical packaging lines: An analytical methodology proposal and case study. INTERNATIONAL JOURNAL OF ENGINEERING BUSINESS MANAGEMENT, 6(1), 1-10 [10.5772/58938].
Benedetti, M; Cesarotti, V; Giuiusa, A; Introna, V
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Buffer size design in pharmaceutical packaging lines.pdf

non disponibili

Descrizione: versione dell'editore
Licenza: Non specificato
Dimensione 808.56 kB
Formato Adobe PDF
808.56 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/118523
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact